A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer
返回论文页
Short communication|更新时间:2023-05-16
|
A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer
A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer
Genes & Diseases2023年10卷第2期
作者机构:
1. Department of Neurology, 960th Hospital of PLA,Shandong,Zibo,China,255300
2. Department of Neurology, The Second Affiliated Hospital of Zhengzhou University,Henan,Zhengzhou,China,450014
3. School of Nursing and Health of Zhengzhou University,Henan,Zhengzhou,China,450052
4. Shangqiu Medical College,Henan,Shangqiu,China,476100
5. School of Public Health and Laboratory of Qilu Medical University,Shandong,Zibo,China,255300
A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer[J]. Genes & Diseases, 2023,10(2).
Yutong Wang, Shanshan Wang, Yanmei Cui, et al. A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer[J]. Genes & Diseases, 2023,10(2).
A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer[J]. Genes & Diseases, 2023,10(2). DOI: 10.1016/j.gendis.2022.08.022.
Yutong Wang, Shanshan Wang, Yanmei Cui, et al. A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer[J]. Genes & Diseases, 2023,10(2). DOI: 10.1016/j.gendis.2022.08.022.
A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer